Association between liver diffusion-weighted imaging apparent diffusion coefficient values and other measures of

Nadeen Abu Ata1, Jonathan R Dillman2,3,4, Deep B Gandhi5

  • 1Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.

Abstract

Insights

Quantitative magnetic resonance imaging (MRI) diffusion-weighted imaging (DWI) apparent diffusion coefficient (ADC) values correlate with liver stiffness and sex in pediatric autoimmune liver disease (AILD). These findings suggest liver ADC may aid in predicting liver disease severity.

Area of Science:

  • Radiology
  • Hepatology
  • Pediatric Medicine

Background:

  • Quantitative magnetic resonance imaging (MRI) methods, including diffusion-weighted imaging (DWI), are used to assess liver fibrosis noninvasively.
  • Autoimmune liver disease (AILD) in pediatric patients requires accurate methods for monitoring disease progression and fibrosis severity.

Purpose of the Study:

  • To investigate the associations between liver MRI DWI apparent diffusion coefficient (ADC) values and clinical factors in pediatric patients diagnosed with AILD.
  • To explore the relationship between liver ADC values and other quantitative MRI metrics, such as liver and spleen stiffness and iron-corrected T1 (cT1).

Main Methods:

  • Fifty-seven pediatric AILD patients underwent liver MRI examinations.
  • Liver DWI ADC values, liver and spleen stiffness, and cT1 were measured.
  • Correlations with patient age, sex, and laboratory markers (ALT, total bilirubin, alkaline phosphatase, GGT) were analyzed using Spearman's rank-order correlation and multiple linear regression.

Main Results:

  • Liver ADC values demonstrated moderate correlations with liver stiffness (r=-0.42), spleen stiffness (r=-0.34), whole-liver mean cT1 (r=-0.39), ALT (r=-0.50), and GGT (r=-0.48).
  • Multiple linear regression identified liver stiffness (p=0.0009) and sex (p=0.023) as independent predictors of liver ADC values.
  • Mean liver DWI ADC value was 1.34 (0.14 × 10-3) mm2/s in the study cohort.

Conclusions:

  • Liver DWI ADC values are significantly associated with liver and spleen stiffness, liver cT1, ALT, GGT, and participant sex.
  • Liver stiffness and sex were identified as independent predictors of liver ADC values in multivariable analysis.
  • Liver ADC holds potential as a component in multi-parametric assessments for predicting the severity of chronic liver disease and fibrosis.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
117
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.4K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
414
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
152